Our goal is to educate providers, clinicians and recovery centers of a new resource in the form of our IOP that is cutting edge, evidence-based, holistic and results oriented.
San Diego, CA (PRWEB) November 25, 2014
The Mind & Body Treatment and Research Institute and BRISAS Recovery and Wellness IOP will be open for enrollment Tuesday, November 25th. This program is specifically designed for individuals with daytime responsibilities who need to maintain their daily obligations, and require a substance abuse treatment program able to accommodate that need.
“Our goal is to educate providers, clinicians and recovery centers of a new resource in the form of our IOP that is cutting edge, evidence-based, holistic and results oriented,” says executive medical director, Dr. Keerthy Sunder.
The clinical team will introduce their dual diagnosis based recovery and wellness cutting edge program as well as its structured six week goal oriented protocol utilizing:
- Substance Abuse Education
- Motivational Enhancement Therapy
- Cognitive Behavioral Therapies (including Dialectical Behavioral Modalities)
- Relapse Prevention Training
- Mindfulness Training
- Stress Management
- Communication Skills Training
- Community Resource Facilitation
- Family Education and Support
- Toxicological Monitoring
- Psychiatric and Physician services
BRISAS brings the best of science and art to the delivery of compassionate, holistic, integrated evidence-based care in Addictions and welcomes queries. Guests will have the opportunity to meet the program developers and tour the IOP. The program will take place in La Jolla, San Diego at 1150 Silverado Street. For additional questions, please contact Dr. Keerthy Sunder, MD at 619-393-6663
About Dr. Keerthy Sunder
Dr. Keerthy Sunder, MD is an accomplished physician who has trained in Addiction Medicine, Psychiatry and Obstetrics/Gynecology. He holds Diplomates from the American Board of Psychiatry and Neurology, American Board of Addiction Medicine and the Royal College of Obstetricians and Gynecologists in London, England. He is a Principal Research Investigator for numerous FDA regulated Clinical Trials in Psychiatry and Addiction Medicine .